TAMPA, Fla. — Carter Validus Mission Critical REIT, Inc. (“CVMC REIT”) acquired the Alpharetta Data Center II property for $56.7 million in the fourth quarter of 2014, and the Landmark Hospital of Savannah property for $20.2 million in January 2015.
Alpharetta Data Center II is a 165,000-square-foot enterprise data center facility located in Alpharetta, Georgia. Situated on 14.40 acres, the facility was purpose-built in 1999 to serve as the primary operations center for a financial services company. It was designed to be fault-tolerant and withstand winds up to 200 MPH. The data center supports 10 MW of total load, which is fed from redundant utility substations. It is served by four fiber providers, and includes 50,440 square feet of 36-inch raised floor and 59,746 square feet of supporting infrastructure.
Landmark Hospital of Savannah is a 48,184-square-foot, 50-bed Long-Term Acute Care Hospital (LTACH). Primary services offered at the LTACH include the long-term treatment of patients needing specialized intensive or acute care. The property is located in Savannah, Georgia, the fourth largest city in the state.
“The addition of both the Alpharetta Data Center II and the Landmark Hospital of Savannah properties is representative of our commitment to acquire high-quality, mission critical assets in the healthcare and data center industries,” said John Carter, Chief Executive Officer of CVMC REIT.
Learn more about recent acquisitions here.
About Carter Validus Mission Critical REIT
Carter Validus Mission Critical REIT, Inc., is a real estate investment trust that invests in mission critical real estate assets located throughout the United States. Mission critical real estate assets are purpose-built facilities designed to support the most essential operations of tenants. Carter Validus Mission Critical REIT, Inc. focuses its acquisitions of mission critical assets in the data center and healthcare sectors.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
